Vitro Biopharma
  • Home
  • About Us
    • Stem Cell Technology
    • Frost and Sullivan Award
    • Team Members
    • White Papers
    • Strategic Partners
  • Products
    • Cell Culture Media
    • Cell Lines
    • Nutravivo-Dietary-Supplements
  • Services
    • Biomarker Profiling
  • Investor Relations
  • Blogs
  • Contact Us
  • My Account
    • Account details
    • Orders
    • Addresses
    • Logout
  • 0 $0.00
Select Page
  • Home
  • About Us
    • Stem Cell Technology
    • Frost and Sullivan Award
    • Team Members
    • White Papers
    • Strategic Partners
  • Products
    • Cell Culture Media
    • Cell Lines
    • Nutravivo-Dietary-Supplements
  • Services
    • Biomarker Profiling
  • Investor Relations
  • Blogs
  • Contact Us
  • My Account
    • Account details
    • Orders
    • Addresses
    • Logout
  • 0 $0.00

Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations

by Tiana Tonrey | Oct 2, 2019 | Press Release, Press Releases

Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations Golden, Colorado-September 25th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations....

Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations

by Tiana Tonrey | Jun 18, 2019 | Press Release, Press Releases

Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations Golden, Colorado-June 19th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro...

Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative

by Tiana Tonrey | Apr 30, 2019 | Press Release, Press Releases

Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™,  Brain Grow...

Vitro Biopharma Obtains CLIA Certification

by Tiana Tonrey | Apr 29, 2019 | Press Release, Press Releases

Vitro Biopharma Obtains CLIA Certification Adding a New Dimension to its Ongoing Stem Cell Clinical Trials Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical...

Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations

by Tiana Tonrey | Mar 24, 2019 | Press Release, Press Releases

Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations.  Vitro...

Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health

by Tiana Tonrey | Mar 14, 2019 | Press Release, Press Releases

Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...
« Older Entries

Product categories

Categories

  • Blogs
  • Company News
  • Press Release
  • Press Releases
  • Technical Content
  • White Papers

Archives

Top Rated Products!

  • Human Stem Cell Basal Medium: 500 ml $75.00
  • Placeholder Cardiovascular Panel 3

Copyright 2018 VitroBioPharma | All Rights Reserved. Privacy & Conditions

View Cart Checkout Continue Shopping